A single dose, open-label study assessing pharmacokinetics, safety and tolerability of hydromorphone after a single oral administration to Japanese volunteers without an opioid antagonist.
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 07 Dec 2015 New trial record